These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9272722)

  • 21. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum.
    Gilbert DB; Millar J; Cooper SJ
    Brain Res; 1995 May; 681(1-2):1-7. PubMed ID: 7552265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of putative dopamine D3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats.
    Kurashima M; Domae M; Inoue T; Nagashima M; Yamada K; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1996 Feb; 53(2):379-83. PubMed ID: 8808147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors.
    Aretha CW; Galloway MP
    Eur J Pharmacol; 1996 Jun; 305(1-3):119-22. PubMed ID: 8813541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes.
    Clos MV; García-Sanz A; Vivas NM; Badia A
    Br J Pharmacol; 1997 Sep; 122(2):286-90. PubMed ID: 9313937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine.
    Baker LE; Svensson KA; Garner KJ; Goodwin AK
    Eur J Pharmacol; 1998 Oct; 358(2):101-9. PubMed ID: 9808258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists.
    Mao A; Freeman KA; Tallarida RJ
    Life Sci; 1996; 59(21):PL317-24. PubMed ID: 8937509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.
    Garner KJ; Baker LE
    Pharmacol Biochem Behav; 1999 Oct; 64(2):373-8. PubMed ID: 10515316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret.
    Yoshikawa T; Yoshida N; Hosoki K
    Eur J Pharmacol; 1996 Apr; 301(1-3):143-9. PubMed ID: 8773458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.
    Oswiecimska J; Brus R; Szkilnik R; Nowak P; Kostrzewa RM
    Pharmacol Biochem Behav; 2000 Sep; 67(1):11-5. PubMed ID: 11113478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.
    Depoortere R; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):31-4. PubMed ID: 10638632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
    Christian AJ; Goodwin AK; Baker LE
    Pharmacol Biochem Behav; 2001 Mar; 68(3):371-7. PubMed ID: 11325388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of 7-OH-DPAT, dopamine D3-receptor agonist, on nucleus accumbens neurons.
    Amano T; Matsubayashi H; Momiyama T; Sasa M
    Jpn J Pharmacol; 1994 Jul; 65(3):293-5. PubMed ID: 7799531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
    Shimizu S; Tatara A; Sato M; Sugiuchi T; Miyoshi S; Andatsu S; Kizu T; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():157-62. PubMed ID: 24368396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ; Girardon S; Monneyron S; Dekeyne A
    Neuropharmacology; 2000 Feb; 39(4):586-98. PubMed ID: 10728880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R(+)-8-OH-DPAT, a selective 5-HT(1A) receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex.
    Kuroki T; Dai J; Meltzer HY; Ichikawa J
    Brain Res; 2000 Jul; 872(1-2):204-7. PubMed ID: 10924694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.